Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades.
Similar Posts
German export sentiment improves in November – Ifo
Post Content Post Views: 134
European Central Bank reports AI boosts high-skilled employment during recession
Post Content Post Views: 138
Ituran Location Q3 Earnings Preview
Post Content Post Views: 149
US thwarted plot to kill Sikh separatist in America
Post Content Post Views: 137
Asia-Pacific stocks turn lower as China property stocks plunge
Post Content Post Views: 142
China consumption shows ‘no sign’ of a strong V-shaped recovery, McKinsey says
China’s consumer isn’t going to be spending big anytime soon, which means companies need to be more strategic to tap the massive market, according to McKinsey. Post Views: 154